Total Payments
$66,826
2024 Payments
$26.13
Companies
21
Transactions
100
Medicare Patients
552
Medicare Billing
$103,985
Payment Breakdown by Category
Consulting$35,235 (52.7%)
Other$23,540 (35.2%)
Travel$5,320 (8.0%)
Food & Beverage$2,452 (3.7%)
Education$279.94 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,235 | 17 | 52.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,540 | 9 | 26.2% |
| Honoraria | $6,000 | 2 | 9.0% |
| Travel and Lodging | $5,320 | 29 | 8.0% |
| Food and Beverage | $2,452 | 40 | 3.7% |
| Education | $279.94 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $17,722 | 12 | $0 (2019) |
| EUSA Pharma (US) LLC | $10,319 | 18 | $0 (2020) |
| Kite Pharma, Inc. | $10,066 | 12 | $0 (2020) |
| Pharmacyclics LLC, An AbbVie Company | $8,692 | 12 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $6,297 | 7 | $0 (2018) |
| Aurobindo Pharma USA, Inc. | $4,534 | 6 | $0 (2019) |
| Seattle Genetics, Inc. | $4,104 | 14 | $0 (2019) |
| Acrotech Biopharma LLC | $1,950 | 2 | $0 (2022) |
| Adaptive Biotechnologies Corporation | $1,500 | 1 | $0 (2020) |
| Secura Bio, Inc. | $804.95 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.13 | 1 | Abbott Laboratories ($26.13) |
| 2023 | $13.11 | 1 | Genentech USA, Inc. ($13.11) |
| 2022 | $1,950 | 2 | Acrotech Biopharma LLC ($1,950) |
| 2021 | $4,930 | 5 | Pharmacyclics LLC, An AbbVie Company ($4,125) |
| 2020 | $12,439 | 9 | Kite Pharma, Inc. ($5,390) |
| 2019 | $21,198 | 37 | AstraZeneca Pharmaceuticals LP ($6,984) |
| 2018 | $15,283 | 28 | Merck Sharp & Dohme Corporation ($6,297) |
| 2017 | $10,987 | 17 | AstraZeneca Pharmaceuticals LP ($6,713) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Neuromodulation | ||||||
| 06/16/2023 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: BioOncology | ||||||
| 05/31/2022 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: ONCOLOGY | ||||||
| 03/31/2022 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| Category: ONCOLOGY | ||||||
| 07/01/2021 | Secura Bio, Inc. | FARYDAK (Drug), COPIKTRA | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: ORAL ONCOLOGIC | ||||||
| 05/24/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| Category: ONCOLOGY | ||||||
| 05/20/2021 | Secura Bio, Inc. | FARYDAK (Drug), COPIKTRA | Consulting Fee | Cash or cash equivalent | $54.95 | General |
| Category: ORAL ONCOLOGIC | ||||||
| 02/02/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2020 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | ||||||
| 12/10/2020 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Oncology | ||||||
| 11/27/2020 | Kite Pharma, Inc. | Tecartus (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: CELLT | ||||||
| 10/09/2020 | EUSA Pharma (US) LLC | Sylvant (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Hematology | ||||||
| 09/14/2020 | Kite Pharma, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,590.00 | General |
| 08/11/2020 | EUSA Pharma (US) LLC | Sylvant (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Hematology | ||||||
| 07/22/2020 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 05/18/2020 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 01/15/2020 | McKesson Specialty Care Distribution, LLC | — | Food and Beverage | Cash or cash equivalent | $32.73 | General |
| 12/18/2019 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,450.00 | General |
| Category: Oncology | ||||||
| 12/08/2019 | Seattle Genetics, Inc. | — | Food and Beverage | In-kind items and services | $82.28 | General |
| 12/07/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $121.57 | General |
| Category: Oncology | ||||||
| 12/06/2019 | Verastem, Inc. | Copiktra (Drug) | Food and Beverage | In-kind items and services | $94.42 | General |
| Category: Hematology and Oncology | ||||||
| 11/20/2019 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Travel and Lodging | In-kind items and services | $92.33 | General |
| Category: Oncology | ||||||
| 11/16/2019 | Aurobindo Pharma USA, Inc. | Zevalin (Drug) | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| Category: Oncology | ||||||
| 11/16/2019 | Aurobindo Pharma USA, Inc. | Zevalin (Drug) | Food and Beverage | In-kind items and services | $132.56 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 23 | 552 | 5,531 | $340,578 | $103,985 |
Total Patients
552
Total Services
5,531
Medicare Billing
$103,985
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2505 | Injection, pegfilgrastim, 6 mg | Office | 2020 | 14 | 18 | $188,966 | $56,051 | 29.7% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 61 | 82 | $36,326 | $11,080 | 30.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 34 | 59 | $14,160 | $5,328 | 37.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 48 | $12,048 | $4,382 | 36.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 29 | 34 | $11,186 | $4,222 | 37.7% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2020 | 18 | 3,750 | $10,335 | $3,895 | 37.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $7,000 | $2,795 | 39.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 40 | $7,000 | $2,599 | 37.1% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2020 | 36 | 75 | $6,750 | $2,169 | 32.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 13 | $6,344 | $2,160 | 34.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 40 | $6,800 | $2,131 | 31.3% |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | Office | 2020 | 20 | 27 | $5,859 | $1,743 | 29.8% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2020 | 23 | 45 | $4,500 | $1,262 | 28.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 13 | 16 | $3,200 | $1,038 | 32.4% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2020 | 23 | 300 | $10,136 | $1,032 | 10.2% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2020 | 32 | 61 | $3,660 | $936.18 | 25.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 34 | 62 | $4,960 | $780.77 | 15.7% |
| 96377 | Application of on-body injector for injection under skin | Office | 2020 | 11 | 14 | $840.00 | $262.46 | 31.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 34 | 596 | $127.92 | $57.09 | 44.6% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2020 | 11 | 11 | $36.19 | $22.39 | 61.9% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2020 | 29 | 34 | $111.86 | $16.79 | 15.0% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2020 | 11 | 168 | $154.24 | $12.64 | 8.2% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2020 | 12 | 18 | $78.12 | $10.31 | 13.2% |
About Dr. Mitchell Smith, M.D
Dr. Mitchell Smith, M.D is a Medical Oncology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013939206.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Smith, M.D has received a total of $66,826 in payments from pharmaceutical and medical device companies, with $26.13 received in 2024. These payments were reported across 100 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($35,235).
As a Medicare-enrolled provider, Smith has provided services to 552 Medicare beneficiaries, totaling 5,531 services with total Medicare billing of $103,985. Data is available for 1 year (2020–2020), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Other Specialties Medical Oncology
- Location Washington, DC
- Active Since 07/24/2006
- Last Updated 02/24/2017
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1013939206
Products in Payments
- CALQUENCE (Drug) $11,009
- Sylvant (Biological) $6,819
- Yescarta (Drug) $4,676
- Imbruvica (Drug) $4,567
- Zevalin (Drug) $4,534
- IMBRUVICA (Drug) $4,256
- ADCETRIS (Biological) $4,022
- Sylvant (Drug) $3,500
- Tecartus (Drug) $2,800
- BELEODAQ (Drug) $1,950
- clonoSEQ (Device) $1,500
- FARYDAK (Drug) $804.95
- FOUNDATIONONE (Device) $124.79
- Venclexta (Drug) $114.12
- ZEJULA (Drug) $105.95
- Copiktra (Drug) $94.42
- PROCLAIM (Device) $26.13
- Kyprolis (Drug) $16.03
- POLIVY (Biological) $13.77
- Columvi (Biological) $13.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Washington
Dr. Nancy Dawson, M.d, M.D
Medical Oncology — Payments: $2.1M
Medical Oncology $2.1M
Dr. Pashna Munshi, M.d, M.D
Medical Oncology — Payments: $181,342
Medical Oncology $181,342
Dr. Khaled El-Shami, Md, MD
Medical Oncology — Payments: $87,325
Medical Oncology $87,325
Dr. Channing Paller, M.d, M.D
Medical Oncology — Payments: $35,482
Medical Oncology $35,482
Maria Nunes, Md, MD
Medical Oncology — Payments: $26,005
Medical Oncology $26,005
Giampaolo Talamo, Md, MD
Medical Oncology — Payments: $18,208
Medical Oncology $18,208